Oxana Beskrovnaya Dyne Therapeutics, Inc. (DYN) insider trading activity

Oxana Beskrovnaya is Chief Scientific Officer of Dyne Therapeutics, Inc.. Currently has a direct ownership of 140,375 shares of DYN, which is worth approximately $5.14 Million. The most recent transaction as insider was on Sep 18, 2024, when has been sold 2,339 shares (Common Stock) at a price of $34.55 per share, resulting in proceeds of $80,812. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 140K

4.84% 3M change

66.45% 12M change

Total Value Held $5.14 Million

Oxana Beskrovnaya Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 18 2024	SELL Open market or private sale	$80,812 $34.55 p/Share	2,339 Reduced 1.64%	140,375 Common Stock
Sep 11 2024	SELL Open market or private sale	$68,914 $31.89 p/Share	2,161 Reduced 1.49%	142,714 Common Stock
Aug 19 2024	SELL Open market or private sale	$119,938 $45.5 p/Share	2,636 Reduced 1.79%	144,875 Common Stock
Jun 11 2024	SELL Open market or private sale	$66,942 $31.34 p/Share	2,136 Reduced 1.43%	147,511 Common Stock
May 20 2024	SELL Open market or private sale	$1,015,011 $33.36 p/Share	30,426 Reduced 16.9%	149,647 Common Stock
May 20 2024	BUY Exercise of conversion of derivative security	$31,338 $1.03 p/Share	30,426 Added 14.45%	180,073 Common Stock
May 16 2024	SELL Open market or private sale	$76,822 $28.4 p/Share	2,705 Reduced 1.78%	149,647 Common Stock
Mar 11 2024	SELL Open market or private sale	$53,481 $25.7 p/Share	2,081 Reduced 1.35%	152,352 Common Stock
Mar 07 2024	SELL Open market or private sale	$61,342 $25.85 p/Share	2,373 Reduced 1.51%	154,433 Common Stock
Jan 04 2024	SELL Open market or private sale	$769,672 $18.13 p/Share	42,453 Reduced 21.31%	156,806 Common Stock
Jan 04 2024	BUY Exercise of conversion of derivative security	$23,354 $1.03 p/Share	22,674 Added 10.22%	199,259 Common Stock
Jan 03 2024	SELL Open market or private sale	$874,791 $19.3 p/Share	45,326 Reduced 20.43%	176,585 Common Stock
Jan 03 2024	BUY Exercise of conversion of derivative security	$46,685 $1.03 p/Share	45,326 Added 16.96%	221,911 Common Stock
Dec 11 2023	SELL Open market or private sale	$15,726 $10.72 p/Share	1,467 Reduced 0.82%	176,585 Common Stock
Nov 15 2023	BUY Grant, award, or other acquisition	-	93,718 Added 34.48%	178,052 Common Stock
Sep 18 2023	SELL Open market or private sale	$13,512 $9.41 p/Share	1,436 Reduced 1.67%	84,334 Common Stock
Sep 12 2023	SELL Open market or private sale	$15,448 $10.41 p/Share	1,484 Reduced 1.7%	85,770 Common Stock
Jun 13 2023	SELL Open market or private sale	$18,334 $12.43 p/Share	1,475 Reduced 1.66%	87,254 Common Stock
Mar 14 2023	SELL Open market or private sale	$18,875 $13.33 p/Share	1,416 Reduced 1.57%	88,729 Common Stock
Dec 12 2022	SELL Open market or private sale	$7,391 $10.87 p/Share	680 Reduced 0.75%	90,145 Common Stock
Dec 09 2022	BUY Grant, award, or other acquisition	-	40,000 Added 30.58%	90,825 Common Stock
Sep 20 2022	SELL Sale (or disposition) back to the issuer	$19,358 $13.7 p/Share	1,413 Reduced 2.7%	50,825 Common Stock
Sep 15 2022	SELL Sale (or disposition) back to the issuer	$10,004 $14.05 p/Share	712 Reduced 1.34%	52,238 Common Stock
Jun 14 2022	SELL Sale (or disposition) back to the issuer	$3,594 $4.95 p/Share	726 Reduced 1.35%	52,950 Common Stock
Mar 11 2022	SELL Open market or private sale	$6,050 $8.73 p/Share	693 Reduced 1.27%	53,676 Common Stock

Oxana Beskrovnaya

Chief Scientific Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DYN shares.

Notify only if

Value

Insider Trading

Get notified when an Dyne Therapeutics, Inc. insider buys or sells DYN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Dyne Therapeutics, Inc.

Track Activities on DYN

Account